BiOptix Diagnostics acquisition
Company: Riot
The claim, verbatim
The company acquired BiOptix Diagnostics
Source (primary)
Riot PRE 14A filed 2016-10-07 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “32,801 shares of Common Stock held in escrow under an escrow agreement entered into in connection with the Company's acquisition of BiOptix Diagnostics”
How we checked this
Checked on September 29, 2026. The cited source supports every part of this claim.
The proxy statement says repeatedly that the Company acquired BiOptix Diagnostics, Inc. in September 2016, and gives the date as September 12, 2016.
Confirmed in the source:
- Venaxis, Inc. acquired BiOptix Diagnostics, Inc. (on September 12, 2016, per the proxy statement)
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997316001208/appy_pre14a.htm) in full (216,115 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot PRE 14A filed 2016-10-07
Quote: “32,801 shares of Common Stock held in escrow under an escrow agreement entered into in connection with the Company's acquisition of BiOptix Diagnostics”